يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"germ cell testicular tumors"', وقت الاستعلام: 0.31s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Cancer Urology; Том 9, № 2 (2013); 69-72 ; Онкоурология; Том 9, № 2 (2013); 69-72 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2013-9-2

    وصف الملف: application/pdf

    Relation: https://oncourology.abvpress.ru/oncur/article/view/99/117; Заридзе Д.Г. Профилактика рака, руководство для врачей. М.: ИМА-пресс, 2009.; Чиссов В.И., Дарьялова С.Л. Клинические рекомендации. Онкология. М.: ГЭО-ТАР-Медиа, 2006.; Злокачественные новообразования в России в 2010 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В.Старинского. М., 2012.; Dijkstra S.S., Witjes J.A. A patient with bilateral testicular cancer. Ned Tijdschr Geneeskd 2012;156(11):A3392.; McGlynn K.A., Devesa S.S., Sigurdso n A.J. et al. Trends in the incidence of testicular germ cell tumours in the United States. Cancer 2003;97(1):63–70. http://www.ncbi.nlm.nih.gov/pubmed/12491506; Che M., Tamboli P., Ro J.Y. et al. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA 2002 Sep 15;95(6):1228–33.; Moller H., Prener A., Skakkebaek N.E. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy and genital malformations: case-control studies in Denmark. Cancer Causes Control 1996;7(2):264–74. http://www.ncbi.nlm.nih.gov/pubmed/8740739; Weestergaard T., Olsen J.H., Frisch M. et al. Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population based study. Int J Cancer 1996;66(5):627–31. http://www.ncbi.nlm.nih.gov/pubmed/8647624; Géczi L., Gomez F., Bak M., Bodrogi I. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. 2003 May;129(5):309–15. Epub 2003 May 14.; Weissbach L. Organ Preserving Surgery of Malignant Germ Cell Tumors. J Urol 1995;153:90–3.; Heidenreich A., Bonfig R., Derschum W. et al. A conservative approach to bilateral testicular germ cell tumors. J Urol 1995;153:10–3.; Dieckmann K.P., Kulejewski M., Pichlmeier U., Loy V. Albertinen-Krankenhaus Hamburg, Urologische Abteilung, Germany. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. 2007 Jan;51(1):175–83; discussion 183–5. Epub 2006 Jun 13.; Dieckmann K.P., Classen J., Souchon R., Loy V. Management of testicular intraepithelial neoplasia (TIN) – a review based on the principles of evidence-based medicine. 2001 Jan 15;113(1–2):7–14.; Heidenreich A., Moul J.W. Department of Urology and Pediatric Urology, Phillips University, Marburg, Germany. Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? Urol Ann 2011;3(3):115–8.; Heidenreich A., Weissbach L., Höltl W. et al. German Testicular Cancer Study Group. Department of Urology, Philipps-University Marburg, Marburg, Krankenhaus Am Urban, Berlin, Germany.Organ sparing surgery for malignant germ cell tumor of the testis. 2001 Dec;166(6):2161–5.; Von der Maase H., Giwercman A., Skakkebaek N.E. Radiation treatment of carcinoma-in-situ of testis. Lancet 1986;1:624–5.; Fizazi K., Oldenburg J., Dunant A. et al. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol 2008;19(2):259–64. http://www.ncbi.nlm.nih.gov/pubmed/18042838; Hendry W.F., Norman A., Nicholls J. et al. Abdominal relapse in stage 1 nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy. BJU Int 2000;86(1):89–93. http://www.ncbi.n lm.nih.gov/pubmed/10886090; Dieckmann K.P., Loy V., Buttner P. Prevalence of bilateral germ cell tumours and early detection based on contralateral testicular intraepithelial neoplasia. Br J Urol 1993;71(3):340–5. http://www.ncbi.nlm.nih.gov/pubmed/8386582; Tandstad T., Dahl O., Cohn-Cedermar k G. et al. Risk-adapted treatment in clinical stage 1 (CS1), nonseminomatous germ cell testicular cancer (NSGCT), the SWENOTECA management program. Heidenreich A. BJU Int 2009;104(9 Pt B):1346–50. Review.PMID: 19840011 [PubMed – indexed for MEDLINE].; https://oncourology.abvpress.ru/oncur/article/view/99

  2. 2
  3. 3
  4. 4